| Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in EGFR/ALK wild-type advanced non-small cell lung cancer XX Peng, R Yu, X Wu, SY Wu, C Pi, ZH Chen, XC Zhang, CY Gao, ... Journal for Immunotherapy of Cancer 8 (1), 2020 | 140 | 2020 |
| GPIbα is required for platelet-mediated hepatic thrombopoietin generation M Xu, J Li, MAD Neves, G Zhu, N Carrim, R Yu, S Gupta, J Marshall, ... Blood, The Journal of the American Society of Hematology 132 (6), 622-634, 2018 | 75 | 2018 |
| EGFR and ERBB2 germline mutations in Chinese lung cancer patients and their roles in genetic susceptibility to cancer S Lu, Y Yu, Z Li, R Yu, X Wu, H Bao, Y Ding, YW Shao, H Jian Journal of Thoracic Oncology 14 (4), 732-736, 2019 | 51 | 2019 |
| SUV39H1 orchestrates temporal dynamics of centromeric methylation essential for faithful chromosome segregation in mitosis L Chu, T Zhu, X Liu, R Yu, M Bacanamwo, Z Dou, Y Chu, H Zou, ... Journal of molecular cell biology 4 (5), 331-340, 2012 | 44 | 2012 |
| Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer XR Yang, C Pi, R Yu, XJ Fan, XX Peng, XC Zhang, ZH Chen, X Wu, ... Clinical & experimental metastasis 38, 109-117, 2021 | 30 | 2021 |
| Clinical implications of plasma ctDNA features and dynamics in gastric cancer treated with HER2‐targeted therapies C Zhang, Z Chen, X Chong, Y Chen, Z Wang, R Yu, T Sun, X Chen, ... Clinical and Translational Medicine 10 (8), e254, 2020 | 30 | 2020 |
| Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling Z Chen, T Sun, Z Yang, Y Zheng, R Yu, X Wu, J Yan, YW Shao, X Shao, ... Molecular genetics & genomic medicine 8 (2), e1079, 2020 | 27 | 2020 |
| Real-world circulating tumor DNA analysis depicts resistance mechanism and clonal evolution in ALK inhibitor-treated lung adenocarcinoma patients G Hua, X Zhang, M Zhang, Q Wang, X Chen, R Yu, H Bao, J Liu, X Wu, ... ESMO open 7 (1), 100337, 2022 | 20 | 2022 |
| Methylation of PLK1 by SET7/9 ensures accurate kinetochore–microtubule dynamics R Yu, H Wu, H Ismail, S Du, J Cao, J Wang, T Ward, F Yang, P Gui, M Ali, ... Journal of molecular cell biology 12 (6), 462-476, 2020 | 20 | 2020 |
| Application of metagenomic next-generation sequencing in the etiological diagnosis of infective endocarditis during the perioperative period of cardiac surgery: a prospective … X Zeng, J Wu, X Li, W Xiong, L Tang, X Li, J Zhuang, R Yu, J Chen, X Jian, ... Frontiers in cardiovascular medicine 9, 811492, 2022 | 19 | 2022 |
| Genetic aberrations in Chinese pancreatic cancer patients and their association with anatomic location and disease outcomes J Lu, R Yu, R Liu, X Liang, J Sun, H Zhang, H Wu, Z Zhang, YW Shao, ... Cancer Medicine 10 (3), 933-943, 2021 | 15 | 2021 |
| Association of circulating tumor DNA from the cerebrospinal fluid with high‐risk CNS involvement in patients with diffuse large B‐cell lymphoma X Wang, Y Gao, C Shan, M Lai, H He, B Bai, L Ping, Q Rong, R Ai, L Wen, ... Clinical and Translational Medicine 11 (1), 2021 | 13 | 2021 |
| Dynamic cfDNA Analysis by NGS in EGFR T790M-Positive Advanced NSCLC Patients Failed to the First-Generation EGFR-TKIs L Ma, H Li, D Wang, Y Hu, M Yu, Q Zhang, N Qin, X Zhang, X Li, H Zhang, ... Frontiers in Oncology 11, 643199, 2021 | 12 | 2021 |
| Identifying novel oncogenic RET mutations and characterising their sensitivity to RET-specific inhibitors Z Zhao, T Fu, J Gao, Y Xu, X Wu, W Chen, X Li, R Yu, YW Shao, M Li, ... Journal of medical genetics 58 (2), 79-86, 2021 | 11 | 2021 |
| Genetic profiling of cell-free DNA from pleural effusion in advanced lung cancer as a surrogate for tumor tissue and revealed additional clinical actionable targets HY Tu, YS Li, XY Bai, YL Sun, MY Zheng, EE Ke, RQ Liao, BY Jiang, ... Clinical Lung Cancer 23 (2), 135-142, 2022 | 9 | 2022 |
| Clinical implications of EGFR‐associated MAPK/ERK pathway in multiple primary lung cancer N Liang, Z Bing, Y Wang, X Liu, C Guo, L Cao, Y Xu, Y Song, C Gao, ... Clinical and translational medicine 12 (5), e847, 2022 | 8 | 2022 |
| Clinical utility of cerebrospinal fluid-derived circular RNAs in lung adenocarcinoma patients with brain metastases Z Wang, R Yu, X Chen, H Bao, R Cao, AN Li, Q Ou, HY Tu, Q Zhou, X Wu, ... Journal of Translational Medicine 20 (1), 74, 2022 | 7 | 2022 |
| Clinical and molecular characteristics of Chinese non‐small cell lung cancer patients with ERBB2 transmembrane domain mutations Y Fan, J Qiu, R Yu, R Cao, X Chen, Q Ou, X Wu, YW Shao, M Nagasaka, ... Molecular Oncology 14 (8), 1731-1739, 2020 | 6 | 2020 |
| Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI–Treated Non–Small-Cell Lung Cancer Revealed Using NGS-Based Liquid Biopsy M Ding, L Deng, R Yu, D Lu, Y Bai, X Wu, YW Shao, Y Yang Clinical Lung Cancer 20 (3), e229-e232, 2019 | 6 | 2019 |
| Clinical outcome-related cancer pathways and mutational signatures in patients with unresectable esophageal squamous cell carcinoma treated with chemoradiotherapy L Li, J Sun, N Liu, R Yu, J Zhang, J Pang, Q Ou, Y Yin, J Cui, X Yao, ... International Journal of Radiation Oncology* Biology* Physics 115 (2), 382-394, 2023 | 5 | 2023 |
